Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2 Trial of PB127 Myocardial Perfusion Echocardiography to Evaluate and Optimize Additional Ultrasound Imaging Systems

NCT00487903 is registered in ClinicalTrials.gov with Point Biomedical as lead sponsor.

NCT NCT00487903
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00487903 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2 Trial of PB127 Myocardial Perfusion Echocardiography to Evaluate and Optimize Additional Ultrasound Imaging Systems
Lead sponsor
Point Biomedical
Phase
Phase 2
Overall status
Terminated
Start date
September 30, 2007
Completion date
March 31, 2008
Enrollment
40 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery disease, healthy